1 rich Libsyn https://www.libsyn.com 90 600 Prehospital heparin administration in patients with&amp;nbsp;ST-segment elevation myocardial infarction&amp;nbsp;(STEMI)&amp;nbsp;undergoing primary&amp;nbsp;percutaneous coronary intervention (PCI)&amp;nbsp;offers a practical strategy to&amp;nbsp;facilitate&amp;nbsp;early restoration of blood flow in the infarct-related artery before hospital arrival. A key advantage of heparin over other agents studied for this purpose is its low cost, widespread availability, and well-established safety profile, making it&amp;nbsp;highly accessible&amp;nbsp;in diverse care settings. By&amp;nbsp;initiating&amp;nbsp;anticoagulation early, this approach aims to support reperfusion without introducing&amp;nbsp;additional&amp;nbsp;harm. Given these benefits, it has strong potential for translation into routine clinical practice, particularly in systems focused on rapid, prehospital STEMI care.&amp;nbsp; &amp;nbsp; In this interview, Kim Allan Williams Sr., MD, MACC&amp;nbsp;and&amp;nbsp;Misa Fister, MD, PhD&amp;nbsp;examine&amp;nbsp;‘Prehospital Heparin Administration&amp;nbsp;In&amp;nbsp;Patients&amp;nbsp;With&amp;nbsp;STEMI Undergoing Primary PCI’.&amp;nbsp; ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research http://accelaccorg.libsyn.com/website <iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/41729585/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no" allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen></iframe> https://assets.libsyn.com/secure/content/203197240